Peprotech, Inc
PeproTech, founded in 1988 and acquired by Thermo Fisher Scientific in 2021, develops and produces recombinant cytokines, growth factors, and related proteins for life science researchers, biotech firms, and biotherapeutics developers, including GMP-grade materials for cell and gene therapy manufacturing under the Gibco brand.
- Company typePrivate
- Founded1988
- HeadquartersRocky Hill, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Peprotech, Inc does
PeproTech, Inc. is a biotechnology company founded in 1988 and headquartered in Rocky Hill, United States, specializing in the development and production of recombinant cytokines, growth factors, chemokines, neurotrophins, proteases, enzymes, ligands, and receptors based on human, mouse, and rat sequences. The company produces these proteins using bacterial (E. coli), mammalian (HEK293, CHO), and insect cell expression systems, with rigorous in-house quality control spanning N-terminal sequencing, SDS-PAGE, RP-HPLC, mass spectrometry, endotoxin testing, and biological activity assays. PeproTech serves life science researchers, biotech companies, and pharma/biotherapeutics developers, with applications spanning cell culture, signaling pathway research, organoid and 3D disease models, tumor models, and cell and gene therapy production.
Since its acquisition by Thermo Fisher Scientific in 2021, PeproTech has operated as a wholly-owned subsidiary brand under the Gibco portfolio. Its product portfolio spans Research Use Only (RUO) recombinant proteins, animal-origin-free cytokines produced in dedicated facilities with endotoxin levels below 0.1 EU/µg, and PeproGMP-grade cytokines manufactured to meet standards for advanced therapy medicinal product (ATMP) clinical manufacturing. Revenue is generated through one-time product sales of recombinant proteins, distributed globally via Thermo Fisher's e-commerce platform (thermofisher.com), field sales force, and eProcurement systems targeting enterprise biotech and pharma buyers. Pricing is catalog-based for RUO products and quote-based for GMP products, with no public disclosure of standalone financials given its subsidiary status.
Peprotech, Inc firmographics
Firmographics- Name
- Peprotech, Inc
- Legal name
- PeproTech, Inc.
- Website
- https://peprotech.com
- Company type
- Private
- Founded year
- 1988
- Operating status
- Acquired
- Headcount range
- 51–100 employees
- Short description
- PeproTech, founded in 1988 and acquired by Thermo Fisher Scientific in 2021, develops and produces recombinant cytokines, growth factors, and related proteins for life science researchers, biotech firms, and biotherapeutics developers, including GMP-grade materials for cell and gene therapy manufacturing under the Gibco brand.
- Ownership category
- akta.pro rank
Peprotech, Inc industry classification
Industry- Product category
- Recombinant Proteins / Life Science Reagents
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Therapeutic Peptides & Protein/Peptide Biologics (HLAAAAAH)
- akta.pro secondary industry
- Specialty & Novel Proteins (Single-Cell Protein, Cell-Cultured/Animal-Free Proteins) (AFAJAHAL)
Keywords
Where Peprotech, Inc is headquartered
LocationHeadquarters
- HQ city
- Rocky Hill
- HQ country
- United States
- HQ region
- North America
Markets served
Peprotech, Inc business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Operations, Personnel
Revenue model
- Recombinant Protein Product Sales: PeproTech generates revenue through the sale of recombinant cytokines, growth factors, chemokines, and other proteins under both Research Use Only (RUO) and GMP-grade formulations for life science research through clinical development. The company serves the cell and gene therapy market by providing well-characterized ancillary materials.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels1 record
Peprotech, Inc product offering
Product offeringCore offering
PeproTech develops and manufactures recombinant cytokine and protein products — including cytokines, growth factors, chemokines, neurotrophins, proteases, enzymes, ligands, and receptors — for life-science research. The company offers both Research Use Only (RUO) and GMP-grade (PeproGMP) product lines, with animal-origin-free options available for human, mouse, and rat sequences.
Product overview
PeproTech, acquired by Thermo Fisher Scientific in 2021, offers a comprehensive portfolio of recombinant proteins under the Gibco brand, encompassing both research-use-only (RUO) and GMP-grade products. The portfolio includes PeproTech recombinant proteins (cytokines, growth factors, chemokines, neurotrophins, proteases, enzymes, ligands, and receptors), Gibco PeproGMP cytokines for clinical cell and gene therapy manufacturing, RUO recombinant cytokines with rigorous quality control testing, and animal-free cytokines produced in dedicated animal-free facilities. These products serve applications across stem cell research, 3D cell culture/organoid models, cancer cell biology, neurobiology, immunology, and cardiovascular research, supporting the RUO-to-GMP transition for biotherapeutics developers.
Differentiator
Problem solved
Functional benefit
Brands
- PeproGMP: GMP-grade recombinant cytokines and growth factors for clinical and advanced therapy medicinal product (ATMP) manufacturing. Based on human sequences and produced in E. coli, designed for clinical trials and cell therapy production.
Products and services
- Recombinant Cytokines, Growth Factors, Chemokines, Neurotrophins, Proteases, Enzymes, Ligands, and Receptors
Companies that use Peprotech, Inc
Customer profileSegments2 records
Ideal customer profiles2 records
Peprotech, Inc technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Peprotech, Inc partnerships and signals
Strategic signalScale indicators1 record
Recent moves4 records
Expansion highlights4 records
Peprotech, Inc competitors and assessment
Company assessmentBroad incumbents
- Abcam: Abcam (now part of Danaher) supplies a broad portfolio of life science research tools including recombinant proteins and antibodies. While not focused solely on cytokines, it competes with PeproTech across the research reagent purchasing workflow of biotech customers.
- Revvity (BioLegend): Revvity's BioLegend brand supplies recombinant cytokines, antibodies, and flow cytometry reagents for life science research. It competes with PeproTech in the immunology and cell biology reagent market and serves overlapping biotech and academic customers.
Direct peers
- CellGenix: CellGenix specializes in GMP-grade cytokines and growth factors for cell and gene therapy manufacturing, directly competing with PeproGMP. It is a focused specialist in the clinical ancillary materials space with deep regulatory documentation.
- StemCell Technologies: StemCell Technologies supplies cytokines, growth factors, and cell culture media for stem cell research and cell therapy development. It competes with PeproTech across RUO and GMP reagent categories, particularly in the stem cell and regenerative medicine research market.
- Miltenyi Biotec: Miltenyi Biotec manufactures recombinant cytokines and growth factors for cell therapy and immunology research, including GMP-grade products. It overlaps significantly with PeproTech's PeproGMP line and competes for cell and gene therapy ancillary material business.
- Bio-Techne (R&D Systems): Bio-Techne's R&D Systems brand is the market-leading recombinant cytokine and growth factor supplier for life science research. It directly competes with PeproTech across RUO and GMP product lines and is the closest comparable in terms of catalog breadth, brand recognition, and scientific publication footprint.
- Akron Biotech: Akron Biotech manufactures GMP-grade cytokines, growth factors, and ancillary materials for cell and gene therapy developers. It is a direct competitor in the PeproGMP addressable market for ATMP manufacturing inputs.
Emerging players
- GenScript: GenScript offers recombinant protein production services and catalog reagents, including cytokines and growth factors. It competes with PeproTech in both research reagents and custom protein production services.
- Sino Biological: Sino Biological is a Chinese manufacturer of recombinant proteins, antibodies, and cytokines with a rapidly expanding catalog. It competes with PeproTech on price across research-grade reagents and is gaining share in international markets.
- Proteintech: Proteintech manufactures antibodies and recombinant proteins for life science research with a growing catalog of cytokines and growth factors. It competes with PeproTech primarily in the academic and biotech RUO reagent market.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Peprotech, Inc social profiles
Digital presencePeprotech, Inc financial estimates
Financial estimateRevenue estimate
Valuation estimate
Peprotech, Inc leadership team
Management profileNumber of profiles
Profiles2 records
Peprotech, Inc funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Peprotech, Inc M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Peprotech, Inc
What does Peprotech, Inc do?
PeproTech develops and manufactures recombinant cytokine and protein products — including cytokines, growth factors, chemokines, neurotrophins, proteases, enzymes, ligands, and receptors — for life-science research. The company offers both Research Use Only (RUO) and GMP-grade (PeproGMP) product lines, with animal-origin-free options available for human, mouse, and rat sequences.
Is Peprotech, Inc a public or private company?
Peprotech, Inc is a private company. It is classified as corporate owned and is currently acquired.
When was Peprotech, Inc founded?
Peprotech, Inc was founded in 1988. It employs 51 to 100 people.
Where is Peprotech, Inc based?
Peprotech, Inc is headquartered in Rocky Hill, United States, in the North America region.
How does Peprotech, Inc make money?
One revenue line is on record: recombinant Protein Product Sales.
Who are Peprotech, Inc's main competitors?
Broad incumbents on record are Abcam and Revvity (BioLegend). Direct peers are CellGenix, StemCell Technologies, Miltenyi Biotec, Bio-Techne (R&D Systems) and Akron Biotech. Emerging players are GenScript, Sino Biological and Proteintech.
Does Peprotech, Inc have an API?
No public API is recorded for Peprotech, Inc.
What industry is Peprotech, Inc in?
Peprotech, Inc's product category is Recombinant Proteins / Life Science Reagents. Its primary akta.pro industry code is HLAAAAAH, Therapeutic Peptides & Protein/Peptide Biologics, with a secondary code of AFAJAHAL, Specialty & Novel Proteins (Single-Cell Protein, Cell-Cultured/Animal-Free Proteins). Its NAICS code is 325414 and its SIC code is 2836.